• FAQ
  • Glossary
Fermer

FAQ

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Voir toutes les FAQ

Fermer

Glossary

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

Voir le glossaire complet

EMA Support for advanced therapy developers

Summarised in this page are a range of advisory services and incentives the European Medicines Agency (EMA) offers for supporting the development of ATMPs.

ema

EMA support for advanced therapy developers

Go to Resource

Back to EMA Resources

Back to Research Pathways

Liens externes

Related pages

EMA teaser

ATMP Overview

Resource
ema

EMA Guidelines relevant for advanced therapy medicinal products

Resource
EMA infosheet

EMA tools for academic medicine developers

Resource
Retour en haut de page
Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires